To test this hypothesis, the half-maximal inhibitory concentration (IC50) for CB-839 was assessed in NE2 and NE3 cells with low RBM4 expression and ESCC cells with high RBM expression. The gene discussed is RBM4; the disease is esophageal squamous cell carcinoma.